BelvilleD. W., CoxD. H., MahanE. D., StutzmanRay E., BruceA. W.: Prostatic acid phosphatase liv radioimmunoassay tumor marker in bone marrow. J. Urol., 121; 442 (1979).
2.
CooperF. J., FotiA. G.: A radioimmunoassay for prostatic acid phosphatase. Invest. Urol., 12; 98 (1974).
3.
CooperF. J., FotiA. G., ShankP. W.: Radioimmunochemical measurement of bone marrow prostatic acid phosphatase. J. Urol., 119; 392 (1978).
4.
CooperF. J., FotiA. G., HerschmanH.: Combined scrum and bone marrow radioimmunoassays for prostatic acid phosphatase. J. Urol., 122; 498 (1979).
5.
DowD., WhitakerR. H.: Prostatic contribution to normal serum acid phosphatase. Brit, med., J., 4; 470 (1970).
6.
FotiA. G., HerschmanH., CooperJ. F.: Comparison of human prostatic acid phosphatase by measurement of enzymatic activity and by radioimmunoassay. Clin. Chem., 23; 95 (1977).
7.
GutmanE. B., SproniE. E., GutmanA. B.: Significance of increased phosphatase activity of bone at side of osteoplastic metastates secondary to carcinoma of prostate gland. Amer. J. Cancer, 28; 485 (1936).
